100 related articles for article (PubMed ID: 1631737)
1. [Antibodies against Entamoeba histolytica in the Mexican Republic. 1974].
Gutiérrez G; Ludlow A; Espinoza G; Herrera S; Muńoz O; Rattoni N; Sepúlveda B
Salud Publica Mex; 1992; 34(2):242-54. PubMed ID: 1631737
[No Abstract] [Full Text] [Related]
2. Seroprevalence of anti-entamoeba histolytica antibodies by IHA and ELISA assays in blood donors from Puebla, Mexico.
del Carmen Sánchez-Guillén M; Velázquez-Rojas M; Salgado-Rosas H; Torres-Rasgado E; Pérez-Fuentes R; Martínez-Munguía J; Talamás-Rohana P
Arch Med Res; 2000; 31(4 Suppl):S53-4. PubMed ID: 11070221
[No Abstract] [Full Text] [Related]
3. Seroepidemiology of anti-Entamoeba histolytica antibody by enzyme-linked immunosorbent assay in the greater Tokyo area.
Tanaka T; Kaneda Y
Tokai J Exp Clin Med; 1991 Dec; 16(5-6):253-8. PubMed ID: 1820666
[TBL] [Abstract][Full Text] [Related]
4. Seroepidemiology of amebiasis in Mexico.
Caballero-Salcedo A; Viveros-Rogel M; Salvatierra B; Tapia-Conyer R; Sepulveda-Amor J; Gutierrez G; Ortiz-Ortiz L
Am J Trop Med Hyg; 1994 Apr; 50(4):412-9. PubMed ID: 8166347
[TBL] [Abstract][Full Text] [Related]
5. Pathogenic and non-pathogenic zymodemes of Entamoeba histolytica in a rural area of Mexico. Concordance with serology.
Martínez-García MC; Muñoz O; Garduño-Rodríguez G; Sánchez-Pares ME; Valadez-Salazar A; Palacios-Beristain O; Calderón-Segura M; Isibasi-Araujo A; Gutiérrez G
Arch Invest Med (Mex); 1990; 21 Suppl 1():147-52. PubMed ID: 2136479
[TBL] [Abstract][Full Text] [Related]
6. [Seroepidemiology of amebiasis in the northern region of the Republic of Mexico].
Isibasi A; González C; Ortíz V; Muy M; Paniagua J; Blanco F; Pelayo R; Magdaleno V; Ramírez A; Kumate J
Arch Invest Med (Mex); 1990; 21 Suppl 1():163-74. PubMed ID: 2136482
[TBL] [Abstract][Full Text] [Related]
7. [Entamoeba histolytica].
Tanabe M; Kobayashi S; Takeuchi T
Nihon Rinsho; 1999 Nov; 57 Suppl():241-4. PubMed ID: 10635824
[No Abstract] [Full Text] [Related]
8. Entamoeba histolytica and Entamoeba dispar: prevalence infection in a rural Mexican community.
Ramos F; Morán P; González E; García G; Ramiro M; Gómez A; de León Mdel C; Melendro EI; Valadez A; Ximénez C
Exp Parasitol; 2005 Jul; 110(3):327-30. PubMed ID: 15955333
[TBL] [Abstract][Full Text] [Related]
9. Study of human Entamoeba histolytica infection by zymodeme, indirect hemagglutination and electroimmunotransfer blot assays.
Sánchez-Guillén MC; Argüello-García R; Garduño G; Valadez-Salazar A; Martínez-García MC; Muñoz O; Ortega-Pierres MG
Arch Invest Med (Mex); 1990; 21 Suppl 1():209-15. PubMed ID: 2136487
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic tests: Entamoeba histolytica].
Kobayashi S; Maeda T; Takeuchi T
Nihon Rinsho; 2005 Jul; 63 Suppl 7():277-9. PubMed ID: 16111248
[No Abstract] [Full Text] [Related]
11. Detection of anti-Entamoeba histolytica IgA salivary antibodies: evaluation of its diagnostic capability in a rural setting.
Escandón Romero C; Gómez Hernández JL; Cabral Soto J; Hernández Ramos JM; Escobedo-de la Peña J; Olvera Alvarez J
Arch Med Res; 1997; 28 Spec No():306-8. PubMed ID: 9033112
[No Abstract] [Full Text] [Related]
12. Opportunities and obstacles in developing a vaccine for Entamoeba histolytica.
Miller-Sims VC; Petri WA
Curr Opin Immunol; 2002 Oct; 14(5):549-52. PubMed ID: 12183151
[TBL] [Abstract][Full Text] [Related]
13. Protective immunity to entamoeba histolytica infection in subjects with antiamoebic antibodies residing in a hyperendemic zone.
Choudhuri G; Prakash V; Kumar A; Shahi SK; Sharma M
Scand J Infect Dis; 1991; 23(6):771-6. PubMed ID: 1815341
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of Entamoeba histolytica infection in female outpatients at a sexually transmitted disease sentinel clinic in Tokyo, Japan.
Suzuki J; Kobayashi S; Iku I; Murata R; Yanagawa Y; Takeuchi T
Jpn J Infect Dis; 2008 May; 61(3):175-8. PubMed ID: 18503164
[TBL] [Abstract][Full Text] [Related]
15. [Seroepidemiological study on amoebiasis].
Zhang TH
Zhonghua Liu Xing Bing Xue Za Zhi; 1988 Aug; 9(4):217-9. PubMed ID: 2906569
[No Abstract] [Full Text] [Related]
16. Estimating the impact of amebiasis on health.
Petri WA; Haque R; Lyerly D; Vines RR
Parasitol Today; 2000 Aug; 16(8):320-1. PubMed ID: 10900473
[No Abstract] [Full Text] [Related]
17. Outbreak of amebiasis in Tbilisi, Republic of Georgia, 1998.
Barwick RS; Uzicanin A; Lareau S; Malakmadze N; Imnadze P; Iosava M; Ninashvili N; Wilson M; Hightower AW; Johnston S; Bishop H; Petri WA; Juranek DD
Am J Trop Med Hyg; 2002 Dec; 67(6):623-31. PubMed ID: 12518853
[TBL] [Abstract][Full Text] [Related]
18. Infection by human immunodeficiency virus-1 is not a risk factor for amebiasis.
Morán P; Ramos F; Ramiro M; Curiel O; González E; Valadez A; Gómez A; García G; Melendro EI; Ximénez C
Am J Trop Med Hyg; 2005 Aug; 73(2):296-300. PubMed ID: 16103593
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of Entamoeba histolytica infection among men who have sex with men in Sydney, Australia.
James R; Barratt J; Marriott D; Harkness J; Stark D
Am J Trop Med Hyg; 2010 Oct; 83(4):914-6. PubMed ID: 20889891
[TBL] [Abstract][Full Text] [Related]
20. Higher seroprevalence of Entamoeba histolytica infection is associated with human immunodeficiency virus type 1 infection in Taiwan.
Tsai JJ; Sun HY; Ke LY; Tsai KS; Chang SY; Hsieh SM; Hsiao CF; Yen JH; Hung CC; Chang SC
Am J Trop Med Hyg; 2006 Jun; 74(6):1016-9. PubMed ID: 16760513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
